IDEXX Working Capital vs Cost of Revenue Analysis

IDXX Stock  USD 477.79  0.45  0.09%   
IDEXX Laboratories financial indicator trend analysis is infinitely more than just investigating IDEXX Laboratories recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether IDEXX Laboratories is a good investment. Please check the relationship between IDEXX Laboratories Working Capital and its Cost Of Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

Working Capital vs Cost Of Revenue

Working Capital vs Cost of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of IDEXX Laboratories Working Capital account and Cost of Revenue. At this time, the significance of the direction appears to have no relationship.
The correlation between IDEXX Laboratories' Working Capital and Cost of Revenue is 0.0. Overlapping area represents the amount of variation of Working Capital that can explain the historical movement of Cost of Revenue in the same time period over historical financial statements of IDEXX Laboratories, assuming nothing else is changed. The correlation between historical values of IDEXX Laboratories' Working Capital and Cost of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Working Capital of IDEXX Laboratories are associated (or correlated) with its Cost of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost of Revenue has no effect on the direction of Working Capital i.e., IDEXX Laboratories' Working Capital and Cost of Revenue go up and down completely randomly.

Correlation Coefficient

0.0
Relationship DirectionFlat 
Relationship StrengthInsignificant

Working Capital

The difference between a company’s current assets and current liabilities, indicating the liquidity and operational efficiency of the business.

Cost Of Revenue

Cost of Revenue is found on IDEXX Laboratories income statement and represents the costs associated with goods and services IDEXX Laboratories provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Most indicators from IDEXX Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into IDEXX Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.At this time, IDEXX Laboratories' Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 44.60 in 2024, whereas Selling General Administrative is likely to drop slightly above 194 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit1.9B2.0B2.2B2.3B
Total Revenue3.2B3.4B3.7B3.8B

IDEXX Laboratories fundamental ratios Correlations

0.970.750.730.980.330.910.950.630.980.840.480.99-0.320.970.97-0.920.820.960.770.720.630.110.90.60.54
0.970.70.650.990.390.860.970.520.980.880.360.98-0.420.920.95-0.890.850.890.860.70.650.040.880.580.54
0.750.70.190.750.770.520.770.270.690.460.480.72-0.280.760.8-0.650.920.780.730.570.930.730.490.670.67
0.730.650.190.64-0.390.890.590.750.720.730.330.710.050.740.65-0.750.20.690.190.61-0.06-0.390.820.250.14
0.980.990.750.640.420.860.960.520.990.850.360.99-0.390.940.96-0.90.860.90.850.690.680.10.860.620.58
0.330.390.77-0.390.420.00.47-0.290.320.150.10.35-0.520.310.41-0.220.790.310.720.20.910.740.070.470.51
0.910.860.520.890.860.00.840.670.920.850.30.9-0.190.930.9-0.970.550.830.50.760.31-0.110.890.410.33
0.950.970.770.590.960.470.840.40.970.850.30.97-0.430.930.95-0.890.860.870.830.740.690.150.870.580.53
0.630.520.270.750.52-0.290.670.40.520.390.760.550.180.560.52-0.550.270.730.230.360.11-0.140.610.40.32
0.980.980.690.720.990.320.920.970.520.90.310.99-0.370.960.97-0.940.790.890.780.740.590.030.90.550.5
0.840.880.460.730.850.150.850.850.390.90.090.88-0.320.830.82-0.830.590.70.620.680.35-0.190.820.380.33
0.480.360.480.330.360.10.30.30.760.310.090.390.080.390.34-0.230.410.70.310.120.420.30.380.430.39
0.990.980.720.710.990.350.90.970.550.990.880.39-0.380.960.96-0.910.820.920.80.70.620.060.90.570.51
-0.32-0.42-0.280.05-0.39-0.52-0.19-0.430.18-0.37-0.320.08-0.38-0.27-0.320.3-0.5-0.22-0.630.11-0.48-0.02-0.340.130.2
0.970.920.760.740.940.310.930.930.560.960.830.390.96-0.270.97-0.930.770.920.680.780.590.170.870.570.5
0.970.950.80.650.960.410.90.950.520.970.820.340.96-0.320.97-0.960.830.90.760.80.670.210.830.60.55
-0.92-0.89-0.65-0.75-0.9-0.22-0.97-0.89-0.55-0.94-0.83-0.23-0.910.3-0.93-0.96-0.68-0.82-0.62-0.79-0.48-0.06-0.84-0.49-0.42
0.820.850.920.20.860.790.550.860.270.790.590.410.82-0.50.770.83-0.680.80.940.510.950.490.60.650.65
0.960.890.780.690.90.310.830.870.730.890.70.70.92-0.220.920.9-0.820.80.710.640.660.220.840.620.56
0.770.860.730.190.850.720.50.830.230.780.620.310.8-0.630.680.76-0.620.940.710.40.850.230.610.550.55
0.720.70.570.610.690.20.760.740.360.740.680.120.70.110.780.8-0.790.510.640.40.350.150.640.650.63
0.630.650.93-0.060.680.910.310.690.110.590.350.420.62-0.480.590.67-0.480.950.660.850.350.690.370.590.62
0.110.040.73-0.390.10.74-0.110.15-0.140.03-0.190.30.06-0.020.170.21-0.060.490.220.230.150.69-0.180.430.47
0.90.880.490.820.860.070.890.870.610.90.820.380.9-0.340.870.83-0.840.60.840.610.640.37-0.180.380.28
0.60.580.670.250.620.470.410.580.40.550.380.430.570.130.570.6-0.490.650.620.550.650.590.430.380.97
0.540.540.670.140.580.510.330.530.320.50.330.390.510.20.50.55-0.420.650.560.550.630.620.470.280.97
Click cells to compare fundamentals

IDEXX Laboratories Account Relationship Matchups

IDEXX Laboratories fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.8B2.3B2.4B2.7B3.3B3.4B
Other Current Liab322.9M415.6M458.9M433.7M478.7M502.6M
Total Current Liabilities725.3M582.8M763.6M1.2B951.5M999.1M
Total Stockholder Equity177.5M632.1M690.0M608.7M1.5B1.6B
Property Plant And Equipment Net533.8M555.2M587.7M649.5M702.2M737.3M
Net Debt897.3M524.6M779.2M1.2B493.9M255.9M
Retained Earnings1.6B2.2B2.9B3.6B4.4B4.7B
Accounts Payable72.2M74.6M116.1M110.2M110.6M116.2M
Cash90.3M383.9M144.5M112.5M453.9M476.6M
Non Current Assets Total1.2B1.2B1.5B1.6B1.8B1.9B
Non Currrent Assets Other299.0M337.2M397.4M425.6M448.5M470.9M
Cash And Short Term Investments90.3M383.9M144.5M112.5M453.9M476.6M
Net Receivables269.3M331.4M368.3M400.6M457.4M480.3M
Common Stock Shares Outstanding87.5M86.7M86.6M84.6M84.0M94.9M
Liabilities And Stockholders Equity1.8B2.3B2.4B2.7B3.3B3.4B
Inventory195.0M209.9M269.0M367.8M380.3M399.3M
Other Current Assets125.0M137.5M173.8M220.5M203.6M213.8M
Other Stockholder Equity(1.4B)(1.5B)(2.2B)(2.9B)(2.9B)(2.8B)
Total Liab1.7B1.7B1.7B2.1B1.8B1.9B
Total Current Assets679.6M1.1B955.7M1.1B1.5B1.6B
Non Current Liabilities Total929.3M1.1B983.6M902.2M823.8M865.0M
Intangible Assets58.5M52.5M99.0M97.7M84.5M74.5M
Short Long Term Debt Total987.7M908.5M923.7M1.3B947.9M995.3M
Short Term Debt288.8M50.0M148.5M654.0M325.0M208.6M
Property Plant And Equipment Gross614.5M646.3M1.3B649.5M1.6B1.7B
Accumulated Other Comprehensive Income(46.2M)(53.6M)(53.5M)(77.8M)(71.2M)(67.6M)
Common Stock Total Equity10.6M10.6M10.7M10.7M12.3M9.0M
Common Stock10.6M10.6M10.7M10.7M10.8M9.2M
Other Assets240.2M676.7M893.9M387.5M445.6M467.9M
Treasury Stock(2.3B)(2.6B)(2.8B)(3.6B)(3.2B)(3.1B)
Property Plant Equipment533.8M555.2M587.7M649.5M746.9M784.2M
Current Deferred Revenue41.5M42.6M40.0M37.9M37.2M25.0M
Good Will239.7M243.3M359.3M361.8M366.0M206.0M
Other Liab162.8M220.5M208.4M106.6M122.6M83.3M
Long Term Debt698.9M858.5M775.2M694.4M622.9M380.8M
Net Tangible Assets(120.7M)336.2M690.0M149.3M134.3M141.1M
Noncontrolling Interest In Consolidated Entity264K280K352K707K813.1K853.7K
Retained Earnings Total Equity1.6B2.2B2.9B3.6B4.1B4.3B
Long Term Debt Total698.9M858.5M775.2M694.4M798.5M502.0M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether IDEXX Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IDEXX Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Idexx Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Idexx Laboratories Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for IDEXX Stock analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Is IDEXX Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.121
Earnings Share
10.04
Revenue Per Share
44.073
Quarterly Revenue Growth
0.088
Return On Assets
0.2283
The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.